Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.
The global Stem Cell Therapy Market
is projected to reach USD 401 million by 2026 from USD 187
million in 2021, at a CAGR of 16.5% during the forecast period.
Ask
for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48
Market
Segmentation: -
The adipose tissue-derived MSCs segment accounted
for the largest share of the cell source segment in the stem cell therapy
market in 2020.
Based on the cell source from which stem cells are obtained, the
global stem cell therapy market is segmented into four sources. These include
adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs,
placenta/umbilical cord-derived MSCs, and other cell sources (which includes
human corneal epithelium stem cells, peripheral arterial-derived stem cells,
and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs
accounted for the markets largest share due to their increasing utilization in
treating inflammatory diseases and wounds & injuries. There are several
associated advantages, such as ease of harvesting stem cells by minimally
invasive methods, simplicity of the isolation procedure, and better quality
& proliferation capacity of adipose tissue-derived stem cells.
The musculoskeletal disorders segment accounted for
the largest share of the therapeutic application segment in the stem cell
therapy market in 2020
Based on therapeutic application, the global stem cell therapy
market is segmented into musculoskeletal disorders, wounds & injuries,
cardiovascular diseases, surgeries, inflammatory & autoimmune diseases,
neurological disorders, and other therapeutic applications (which include
ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the
musculoskeletal disorders segment accounted for the largest share of the
therapeutic application segment. The large market share of this segment is
attributed to the increasing prevalence of musculoskeletal disorders such as
osteoarthritis, bone repair, and regeneration.
Regional
Analysis: -
The Asia Pacific region is the fastest-growing
region of the stem cell therapy market in 2020.
The Asia Pacific region is estimated to grow at the highest CAGR
in the stem cell therapy market during the forecast period. Some of the major
factors fueling the growth of the APAC market include regulatory approvals and
guidelines for product approvals and the presence of major stem cell players in
countries such as South Korea, Japan, India, and Australia.
Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48
Top
Key Players: -
Key players in the stem cell therapy market include Smith &
Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South
Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd.
(Japan), and NuVasive, Inc. (US).
No comments:
Post a Comment